Medicare Enrolled

Dr. Joel Hyman, M.D.

Dermatology · The Woodlands, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
9303 PINECROFT DR, The Woodlands, TX 77380
2813635050
In practice since 2006 (19 years)
NPI: 1881774818 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hyman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hyman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hyman

Dr. Joel Hyman is a dermatology specialist in The Woodlands, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hyman performed 5,201 Medicare services across 3,048 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hyman received a total of $47,273 from 42 pharmaceutical and/or device companies across 786 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hyman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 23% volume in TX $47,273 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,201
Medicare services
Top 23% in TX for dermatology
3,048
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~274 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14 1,838 $5 $8
Office visit, established patient (20-29 min) 1,137 $58 $115
Destruction of precancerous skin growth, 1 650 $36 $85
Destruction of skin growths (warts/lesions), 1-14 534 $76 $144
Office visit, established patient (10-19 min) 290 $38 $70
Skin biopsy, tangential 233 $61 $128
New patient office visit (30-44 min) 153 $70 $142
New patient office or other outpatient visit, 15-29 minutes 65 $44 $95
Office visit, established patient (30-39 min) 57 $74 $165
Biopsy of related skin growth, each additional growth 48 $39 $64
Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm 48 $105 $187
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm 40 $129 $226
Destruction of precancer skin growth, 15 or more growths 34 $109 $213
Biopsy of ear 29 $51 $122
Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm 17 $122 $211
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm 17 $118 $228
Destruction of skin growth, 15 or more growths 11 $102 $168
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$47,273
Total received (2018-2024)
Avg $6,753/year across 7 years
Top 8% in TX for dermatology
42
Companies
786
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$28,539 (60.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,567 (28.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,167 (10.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,334
2023
$2,907
2022
$2,457
2021
$2,949
2020
$525
2019
$7,634
2018
$28,467

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$21,121
Galderma Laboratories, L.P.
$9,194
UCB, Inc.
$3,583
Regeneron Healthcare Solutions, Inc.
$3,033
Janssen Biotech, Inc.
$1,614
Lilly USA, LLC
$1,531
ABBVIE INC.
$1,010
PFIZER INC.
$762
AbbVie, Inc.
$749
GENZYME CORPORATION
$696
Amgen Inc.
$637
Sun Pharmaceutical Industries Inc.
$453
AbbVie Inc.
$413
LEO Pharma Inc.
$316
Incyte Corporation
$312
Ortho Dermatologics, a division of Bausch Health US, LLC
$281
Celgene Corporation
$259
E.R. Squibb & Sons, L.L.C.
$187
SUN PHARMACEUTICAL INDUSTRIES INC.
$131
Janssen Scientific Affairs, LLC
$122
Hill Dermaceuticals, Inc.
$120
Arcutis Biotherapeutics, Inc.
$91
EPI Health, LLC
$76
Encore Dermatology Inc.
$74
Genentech USA, Inc.
$67
Allergan, Inc.
$56
Boehringer Ingelheim Pharmaceuticals, Inc.
$43
SANOFI-AVENTIS U.S. LLC
$43
SANOFI US SERVICES INC.
$37
Sandoz Inc.
$34
Mission Pharmacal Company
$30
Mylan Pharmaceuticals Inc.
$28
Dermavant Sciences, Inc.
$28
Almirall LLC
$23
Biofrontera Inc.
$17
DERMIRA, INC.
$17
DUSA Pharmaceuticals, Inc.
$16
Allergan Inc.
$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Avion Pharmaceuticals
$15
Novum Pharma, LLC
$13
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 71.7% of total payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ADBRY · AKLIEF · ARAZLO · Alcortin A · Ameluz · BLU-U · BOTOX · BOTOX COSMETIC · BRYHALI · Bensal HP · Bimzelx · CIBINQO · CLODERM · COSENTYX · CYLTEZO · Cabtreo · Cimzia · Clindamycin Phosphate and Benzoyl Peroxide · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Enbrel · Erivedge · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Impoyz · JUBLIA · KERYDIN · LIBTAYO · Nicomide · OPZELURA · ORACEA · Otezla · REMICADE · RETIN-A-MICRO · RINVOQ · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TREMFYA · TWYNEO · Tolak · Tremfya · VTAMA · Winlevi · XIFAXAN · Xolair · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (60%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in dermatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for dermatology in TX.

Equivalent to $909 per 100 Medicare services performed
Looking for a dermatology specialist in The Woodlands?
Compare dermatologists in the The Woodlands area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
68
Per 100K population
10.4
County median income
$97,266
Nearest hospital
HOUSTON METHODIST THE WOODLANDS HOSPITAL
4.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Hyman is a clinical cardiology specialist, with above-average Medicare volume (top 23% in TX), with speaking/promotional industry engagement in the top 8% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Hyman experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Hyman performed 1,838 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hyman receive payments from pharmaceutical companies?
Yes. Dr. Hyman received a total of $47,273 from 42 companies across 786 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hyman's costs compare to other dermatologists in The Woodlands?
Dr. Hyman's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hyman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →